Autoimmune haemolytic anaemia

Barcellini, 2021, How I treat warm autoimmune hemolytic anemia, Blood., 137, 1283, 10.1182/blood.2019003808 Hill, 2017, The diagnosis and management of primary autoimmune haemolytic anaemia, Br J Haematol., 176, 395, 10.1111/bjh.14478 Berentsen, 2021, Autoimmune hemolytic anemias, N Engl J Med., 385, 1407, 10.1056/NEJMra2033982 Hill, 2017, Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia, Br J Haematol., 177, 208, 10.1111/bjh.14654 Jäger, 2020, Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting, Blood Rev., 41, 10.1016/j.blre.2019.100648 Davis, 2019, Hematologic complications of immune checkpoint inhibitors, Oncologist., 24, 584, 10.1634/theoncologist.2018-0574 Lecouffe-Desprets, 2015, Venous thromboembolism related to warm autoimmune hemolytic anemia: a case-control study, Autoimmun Rev., 14, 1023, 10.1016/j.autrev.2015.07.001 Broome, 2020, Increased risk of thrombotic events in cold agglutinin disease: a 10-year retrospective analysis, Res Pract Thromb Haemost., 4, 628, 10.1002/rth2.12333 Ward, 2008, Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia, Blood., 111, 680, 10.1182/blood-2007-07-101345 Barcellini, 2021, Are patients with autoimmune cytopenias at higher risk of COVID-19 pneumonia? The experience of a reference center in Northern Italy and Review of the Literature, Front Immunol., 11, 6091, 10.3389/fimmu.2020.609198 Fattizzo, 2021, Evans syndrome in adults: an observational multicenter study, Blood Adv., 5, 5468, 10.1182/bloodadvances.2021005610 Berentsen, 2012, Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia, Blood Rev., 26, 107, 10.1016/j.blre.2012.01.002 Berentsen, 2020, Cold agglutinin disease revisited: a multinational, observational study of 232 patients, Blood., 136, 480, 10.1182/blood.2020005674 Randen, 2014, Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma, Haematologica., 99, 497, 10.3324/haematol.2013.091702 Małecka, 2018, Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease, Br J Haematol., 183, 838, 10.1111/bjh.15063 Berentsen, 2019, Novel insights into the treatment of complement-mediated hemolytic anemias, Ther Adv Hematol., 10, 10.1177/2040620719873321 Garbe, 2011, Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study, Br J Haematol., 154, 644, 10.1111/j.1365-2141.2011.08784.x Chan, 2020, Bendamustine-induced immune hemolytic anemia: a case report and systematic review of the literature, Blood Adv., 4, 1756, 10.1182/bloodadvances.2020001726 Khan, 2017, Immunotherapy-associated autoimmune hemolytic anemia, J Immunother Cancer., 5, 15, 10.1186/s40425-017-0214-9 Piva, 2015, Clinical utility of reticulocyte parameters, Clin Lab Med., 35, 133, 10.1016/j.cll.2014.10.004 Sokol, 1999, Erythropoiesis: paroxysmal cold haemoglobinuria: a clinico-pathological study of patients with a positive Donath-Landsteiner test, Hematology., 4, 137, 10.1080/10245332.1999.11746439 Chen, 2020, Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions, Medicine (Baltimore)., 99 Berentsen, 2021, How I treat cold agglutinin disease, Blood., 137, 1295, 10.1182/blood.2019003809 Fattizzo, 2021, Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study, Haematologica., 106, 622, 10.3324/haematol.2020.250522 Barcellini, 2014, Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients, Blood., 124, 2930, 10.1182/blood-2014-06-583021 Birgens, 2013, A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia, Br J Haematol., 163, 393, 10.1111/bjh.12541 Michel, 2017, A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study), Am J Hematol., 92, 23, 10.1002/ajh.24570 Murakhovskaya, 2020, Rituximab use in warm and cold autoimmune hemolytic anemia, J Clin Med., 9, 4034, 10.3390/jcm9124034 Gutiérrez Jomarrón, 2020, Autoimmune haemolytic anaemias: a retrospective study of 93 patients, Med Clin., 154, 331, 10.1016/j.medcli.2019.06.024 Brodsky, 2019, Warm autoimmune hemolytic anemia, N Engl J Med., 381, 647, 10.1056/NEJMcp1900554 Fadlallah, 2019, Bortezomib and dexamethasone, an original approach for treating multi-refractory warm autoimmune haemolytic anaemia, Br J Haematol., 187, 124, 10.1111/bjh.16009 Rieger, 2021, Daratumumab in rituximab-refractory autoimmune haemolytic anaemia, Br J Haematol., 194, 931, 10.1111/bjh.17655 Kuter, 2018, Fostamatinib, a spleen tyrosine kinase inhibitor, for the treatment of warm antibody autoimmune hemolytic anemia: initial results of the multicenter, open-label extension period of the soar phase 2 study, Blood., 132, 3612, 10.1182/blood-2018-99-110483 Lafarge, 2019, Prognosis of autoimmune hemolytic anemia in critically ill patients, Ann Hematol., 98, 589, 10.1007/s00277-018-3553-9 Berentsen, 2020, New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia, Front Immunol., 11, 590, 10.3389/fimmu.2020.00590 Röth, 2018, Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial, Blood Adv., 2, 2543, 10.1182/bloodadvances.2018024190 Grossi, 2018, Inhibition of C3 with APL-2 results in normalisation of markers of intravascular and extravascular hemolysis in patients with autoimmune hemolytic anemia (AIHA), Blood., 132, 3623, 10.1182/blood-2018-99-119468 Roeth, 2021, Inhibition of complement C1s by sutimlimab in patients with cold agglutinin disease (CAD): efficacy and safety results from the randomized, placebo-controlled phase 3 CADENZA study, Blood., 138, 349, 10.1182/blood-2021-148066 Jalink, 2020, Effective treatment of cold agglutinin disease/cold agglutinin syndrome with ibrutinib: an international case series, Blood., 136, 29, 10.1182/blood-2020-139131